XOMA Co. (NASDAQ:XOMAO – Get Free Report) was the recipient of a significant growth in short interest during the month of May. As of May 29th, there was short interest totaling 2,149 shares, a growth of 1,468.6% from the May 14th total of 137 shares. Based on an average daily volume of 4,591 shares, the short-interest ratio is currently 0.5 days.
XOMA Trading Down 0.0%
XOMA stock opened at $25.37 on Thursday. XOMA has a 1-year low of $24.86 and a 1-year high of $26.40. The firm has a 50-day moving average of $25.44 and a 200-day moving average of $25.42.
About XOMA
XOMA Corporation is a clinical-stage biotechnology company specializing in the discovery and development of therapeutic antibodies. The company applies its proprietary protein engineering and antibody optimization platform to generate novel drug candidates targeting autoimmune, inflammatory and metabolic diseases. XOMA’s scientific expertise spans antibody discovery, engineering, in vitro and in vivo testing, and early‐stage clinical development.
In addition to advancing its own pipeline of antibody candidates, XOMA collaborates with pharmaceutical and biotechnology partners to provide research and development services.
Further Reading
- Five stocks we like better than XOMA
- 2 Ways to Play the QXO/TopBuild Deal
- Wolfspeed Ditches EV Woes for High-Margin Defense Jets
- Casey’s Is Looking Like a Hot Buy as Growth, Buybacks, and Guidance Align
- The “Duck Stock” Keeps Quietly Making Money for Shareholders
Receive News & Ratings for XOMA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XOMA and related companies with MarketBeat.com's FREE daily email newsletter.
